{
    "xml": "<topic id=\"PHP85620\" outputclass=\"drug\" rev=\"1.16\" type=\"drug\" namespace=\"/drugs/ipratropium-with-salbutamol\" basename=\"ipratropium-with-salbutamol\" title=\"IPRATROPIUM WITH SALBUTAMOL\">\n<title>IPRATROPIUM WITH SALBUTAMOL </title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_348\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/ipratropium\">Ipratropium</xref>, <xref format=\"dita\" href=\"#bnf_int_726\" namespace=\"/interactions/list-of-drug-interactions/sympathomimetics-beta2/salbutamol\">Salbutamol</xref>\n</p>\r\n<p outputclass=\"constituentDrugs\">The properties listed below are those particular to the combination only. For the properties of the components please consider, <xref format=\"dita\" href=\"#PHP1756\" namespace=\"/drugs/salbutamol\">salbutamol</xref>, <xref format=\"dita\" href=\"#PHP1791\" namespace=\"/drugs/ipratropium-bromide\">ipratropium bromide</xref>.</p>\n<data name=\"vtmid\">421685007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_567112641\" title=\"Antimuscarinics\">Antimuscarinics</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_265796086\" title=\"Beta2 agonists (short-acting)\">Beta2 agonists (short-acting)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP87589\" outputclass=\"indicationsAndDose\" rev=\"1.22\" parent=\"/drugs/ipratropium-with-salbutamol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Bronchospasm in chronic obstructive pulmonary disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of nebulised solution</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.5/2.5&#8239;mg 3&#8211;4 times a day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP87603\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/ipratropium-with-salbutamol\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>A mixture of ipratropium bromide and salbutamol (as sulphate); the proportions are expressed in the form x/y where x and y are the strengths in milligrams of ipratropium and salbutamol respectively.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP87600\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.11\" parent=\"/drugs/ipratropium-with-salbutamol\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p>Ipratropium bromide with salbutamol nebuliser solution is considered less suitable for prescribing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP85620-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ipratropium-with-salbutamol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92270\" title=\"Nebuliser liquid\" namespace=\"/drugs/ipratropium-with-salbutamol/nebuliser-liquid\">Nebuliser liquid</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"2\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_348\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/ipratropium\" title=\"Ipratropium\" count=\"1\" rel=\"link\">Ipratropium</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_726\" namespace=\"/interactions/list-of-drug-interactions/sympathomimetics-beta2/salbutamol\" title=\"Salbutamol\" count=\"1\" rel=\"link\">Salbutamol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1756\" namespace=\"/drugs/salbutamol\" title=\"SALBUTAMOL\" count=\"1\" rel=\"link\">SALBUTAMOL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1791\" namespace=\"/drugs/ipratropium-bromide\" title=\"IPRATROPIUM BROMIDE\" count=\"1\" rel=\"link\">IPRATROPIUM BROMIDE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92270\" namespace=\"/drugs/ipratropium-with-salbutamol/nebuliser-liquid\" title=\"Nebuliser liquid\" count=\"1\" rel=\"link\">Nebuliser liquid</xref>\n</links>\n</topic>",
    "id": "PHP85620",
    "outputclass": "drug",
    "rev": "1.16",
    "type": "drug",
    "namespace": "/drugs/ipratropium-with-salbutamol",
    "basename": "ipratropium-with-salbutamol",
    "title": "IPRATROPIUM WITH SALBUTAMOL",
    "interactants": [
        {
            "id": "bnf_int_348",
            "label": "Ipratropium"
        },
        {
            "id": "bnf_int_726",
            "label": "Salbutamol"
        }
    ],
    "constituents": [
        {
            "id": "PHP1756",
            "label": "salbutamol"
        },
        {
            "id": "PHP1791",
            "label": "ipratropium bromide"
        }
    ],
    "vtmid": "421685007",
    "drugClassification": [
        "Antimuscarinics",
        "Beta2 agonists (short-acting)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Bronchospasm in chronic obstructive pulmonary disease",
                        "html": "Bronchospasm in chronic obstructive pulmonary disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of nebulised solution"
                    ],
                    "textContent": "By inhalation of nebulised solution",
                    "html": "By inhalation of nebulised solution"
                },
                "adult": [
                    {
                        "textContent": "0.5/2.5 mg 3&#8211;4 times a day.",
                        "html": "<p>0.5/2.5&#8239;mg 3&#8211;4 times a day.</p>"
                    }
                ]
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "A mixture of ipratropium bromide and salbutamol (as sulphate); the proportions are expressed in the form x/y where x and y are the strengths in milligrams of ipratropium and salbutamol respectively.",
                "html": "<p>A mixture of ipratropium bromide and salbutamol (as sulphate); the proportions are expressed in the form x/y where x and y are the strengths in milligrams of ipratropium and salbutamol respectively.</p>"
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "textContent": "Ipratropium bromide with salbutamol nebuliser solution is considered less suitable for prescribing.",
                "html": "<p>Ipratropium bromide with salbutamol nebuliser solution is considered less suitable for prescribing.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP92270",
                "label": "Nebuliser liquid",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_348",
                "label": "Ipratropium",
                "type": "interaction"
            },
            {
                "id": "bnf_int_726",
                "label": "Salbutamol",
                "type": "interaction"
            }
        ],
        "drug": [
            {
                "id": "PHP1756",
                "label": "SALBUTAMOL",
                "type": "drug"
            },
            {
                "id": "PHP1791",
                "label": "IPRATROPIUM BROMIDE",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP92270",
                "label": "Nebuliser liquid",
                "type": "medicinalForm"
            }
        ]
    }
}